Mostrando 9 resultados de: 9
Filtros aplicados
Publisher
Revista Latinoamericana de Hipertension(5)
Gaceta Medica de Caracas(2)
American Journal of Therapeutics(1)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Área temáticas
Enfermedades(8)
Bioquímica(2)
Farmacología y terapéutica(2)
Fisiología humana(2)
Salud y seguridad personal(2)
Área de conocimiento
Enfermedad cardiovascular(4)
Medicina interna(3)
Genética(2)
Biología molecular(1)
Bioquímica(1)
Origen
scopus(9)
Diagnostic criteria and management of metabolic syndrome: Evolution overtime
ReviewAbstract: The beginnings of the Metabolic Syndrome (MetS) as a suspected, not yet recognized entity can be traPalabras claves:Cardiovascular disease, Diagnostic criteria, management, Metabolic syndrome, MetS updates, Type 2 DiabetesAutores:Carrasquero R., Castro A., Lameda V., Manzano A., Nava M., Rojas E.R., Suarez M.K., Valmore BermúdezFuentes:scopusAbnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?
ArticleAbstract: Objective. Lipoprotein(a) is an independent risk factor for coronary artery disease. In Venezuela, LPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Arráiz N., Cano-Ponce C., Ciszek A., Faria J., Gotera D., Guerra-Torres X.E., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusHypertension, emotions and happiness: A brief view from the biology to the positive psychology
ArticleAbstract: High blood pressure (HBP) is a silent disease with an extremely high prevalence worldwide. It is conPalabras claves:Cardiovascular disease, happiness, HEALTH, Hypertension, psychosocialAutores:Bautista-Sandoval M.J., Castro A., Chaparro-Suárez Y.K., Díaz-Camargo E.A., Durán P., D’marco L., González M.C., Nava M., Ortiz O.M., Parra H., Riaño-Garzón M.E., Rojas E.R., Valmore BermúdezFuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopusLipoprotein(a): From molecules to therapeutics
ReviewAbstract: Lipoprotein (a) [Lp(a)] was discovered by Kare Berg in 1963 from the study of low-density lipoproteiPalabras claves:Atherogenesis, Cardiovascular disease, Hyperlipoproteinemia(a), lipoprotein(a), therapeuticsAutores:Amell A., Aparicio D., Arráiz N., Cabrera M., Canelón R., Cano R.A., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Mengual-Moreno E., Reyna-Villasmil N., Rojas E.R., Sorell L.T., Valmore Bermúdez, Velasco M.Fuentes:scopusUnusually elevated levels of lipoprotein(a) in Afro-American populations from south of Lake Maracaibo
ArticleAbstract: Objective. Lipoproteína(a), [Lp(a)], is an independent risk factor for coronary artery disease. In VPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Cano-Ponce C., Faria J., Gotera D., Guerra-Torres X.E., Linares S., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusPrevalence, awareness, management of hypertension and association with metabolic abnormalities: The Maracaibo city metabolic syndrome prevalence study
ArticleAbstract: Background: The purpose of this study was to determine the prevalence and epidemiologic behavior ofPalabras claves:Arterial hypertension, Cardiovascular disease, diabetes mellitus, Latin America, obesity, PREVALENCEAutores:Aguirre M.A., Añez-Ramos R., Apruzzese V., Bello L.M., Calvo M.J., Gómez M.C., González M.C., Gonzalez R., Israili Z.H., Lopez-Miranda J., Lubo A., Martínez M.S., Olivar L.C., Rojas E.R., Rojas-Quintero J., Salazar-Vílchez J., Toledo A.C., Valmore Bermúdez, Velasco M., Villalobos M.Fuentes:scopus